Published in Metab Brain Dis on July 27, 2017
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol (2008) 16.65
Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity (2006) 10.61
Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature (2011) 10.16
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature (2008) 9.16
Molecular identification of a danger signal that alerts the immune system to dying cells. Nature (2003) 8.90
Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med (2010) 7.31
Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry (2011) 6.98
Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol (2006) 6.00
Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry (2011) 5.85
Microglia in neurodegenerative disease. Nat Rev Neurol (2010) 5.83
Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res (2010) 5.50
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med (2008) 5.42
Diagnostic change and the increased prevalence of autism. Int J Epidemiol (2009) 4.81
The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur J Immunol (2008) 4.72
Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol (2008) 4.60
Toll-like receptors in the pathogenesis of human disease. Nat Immunol (2004) 4.40
Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol (2008) 3.66
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med (2011) 3.63
Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol (2009) 3.51
Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med (2005) 3.42
Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol (2014) 3.38
DAMPening inflammation by modulating TLR signalling. Mediators Inflamm (2010) 3.29
Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine (2014) 3.18
'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun (2010) 3.14
Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr (2005) 2.98
Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med (2002) 2.88
Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature (1992) 2.82
Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism (2012) 2.67
TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med (2007) 2.62
An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity (2011) 2.57
Emerging roles of astrocytes in neural circuit development. Nat Rev Neurosci (2013) 2.45
Microglia: new roles for the synaptic stripper. Neuron (2013) 2.44
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci U S A (2009) 2.42
DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med (2011) 2.41
A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem (2009) 2.37
Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry (2010) 2.30
Astrocytes and disease: a neurodevelopmental perspective. Genes Dev (2012) 2.28
Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system. JAMA (2015) 2.22
Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging. JAMA Psychiatry (2014) 2.21
TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell (2015) 2.15
Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol (2012) 2.09
Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol (2007) 2.08
Retracted Measles-mumps-rubella vaccination timing and autism among young African American boys: a reanalysis of CDC data. Transl Neurodegener (2014) 2.05
Microglial priming in neurodegenerative disease. Nat Rev Neurol (2014) 2.04
APP processing in Alzheimer's disease. Mol Brain (2011) 2.02
MMR vaccination and pervasive developmental disorders: a case-control study. Lancet (2004) 2.02
Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry (2012) 1.91
Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun (2009) 1.86
Pattern recognition receptors and the innate immune response to viral infection. Viruses (2011) 1.82
Microglia and neurodegeneration: the role of systemic inflammation. Glia (2012) 1.73
Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder. JAMA (2015) 1.70
Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res Bull (2001) 1.69
Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity (2011) 1.65
Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol Psychiatry (2013) 1.60
Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics (2003) 1.58
Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry (2013) 1.57
Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. J Inorg Biochem (2009) 1.55
Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr Opin Neurol (2010) 1.52
Common DNA methylation alterations in multiple brain regions in autism. Mol Psychiatry (2013) 1.51
Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses' Health Study II participants. Environ Health Perspect (2013) 1.49
Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association. Pediatrics (2004) 1.48
Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus. Neurology (2013) 1.46
Normoxic stabilization of HIF-1alpha drives glycolytic metabolism and regulates aggrecan gene expression in nucleus pulposus cells of the rat intervertebral disk. Am J Physiol Cell Physiol (2007) 1.45
Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice. J Neurosci (2008) 1.43
The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol (2009) 1.43
Laser microprobe analysis of brain aluminum in Alzheimer's disease. Ann Neurol (1993) 1.39
Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J Autism Dev Disord (2012) 1.38
Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J Intern Med (2013) 1.37
Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol (1992) 1.33
Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun (2002) 1.31
Microglia during development and aging. Pharmacol Ther (2013) 1.30
Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) (2011) 1.29
Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease. Neurochem Res (2008) 1.27
Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci (2014) 1.26
TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clin Rev Allergy Immunol (2014) 1.25
Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat Commun (2014) 1.25
Cytokine gene polymorphism in human disease: on-line databases, Supplement 3. Genes Immun (2006) 1.24
Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med (2012) 1.24
Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol Neurobiol (2013) 1.23
Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement. Microsc Res Tech (2000) 1.23
Role of oxidative stress in Parkinson's disease. Exp Neurobiol (2013) 1.23
The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders. Front Psychiatry (2012) 1.22
Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. Genet Med (2011) 1.22
Alum adjuvant: some of the tricks of the oldest adjuvant. J Med Microbiol (2011) 1.20
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun (2013) 1.19
TREM2 and the neuroimmunology of Alzheimer's disease. Biochem Pharmacol (2013) 1.18
Immunological and autoimmune considerations of Autism Spectrum Disorders. J Autoimmun (2013) 1.17
Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration. J Immunol (2011) 1.16
Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12. Hum Immunol (2013) 1.16
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum. Expert Rev Clin Immunol (2013) 1.14
Phagocytosis of microglia in the central nervous system diseases. Mol Neurobiol (2014) 1.14
Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci (2015) 1.13
Regulation of TREM2 expression by an NF-кB-sensitive miRNA-34a. Neuroreport (2013) 1.13
TREM2 sustains microglial expansion during aging and response to demyelination. J Clin Invest (2015) 1.12
DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways. Transl Psychiatry (2014) 1.12
Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo. Blood (2010) 1.12
NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome. Proc Natl Acad Sci U S A (2013) 1.12
Cellular defense against singlet oxygen-induced oxidative damage by cytosolic NADP+-dependent isocitrate dehydrogenase. Free Radic Res (2003) 1.12
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause? Mol Neurobiol (2017) 0.75
Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions. Mol Neurobiol (2017) 0.75